+91 7986995600
seclislabs@gmail.com
Contact Us
Home › Cardiovascular Therapy › LEADTEL AM
Cardiovascular Therapy

LEADTEL AM

Telmisartan 40mg + Amlodipine 5mg

Dosage Form Tablet
Packing 10*15 ALU
MRP Max DPCO
Prescribed By Cardiologist, General Physician, Nephrologist, Endocrinologist, Internal Medicine

Quick Facts

Storage Below 30°C, ALU | Schedule: H | Pack: 10×15 (150 tablets) | Once daily

Key Benefits

01
ARB + Calcium Channel Blocker — two complementary antihypertensive mechanisms
02
Telmisartan — renoprotective benefit in diabetic nephropathy
03
Amlodipine — additional anti-anginal benefit
04
150-tablet economy pack for chronic daily therapy
05
Once-daily fixed combination for improved compliance

Mechanism of Action

A dual antihypertensive combination. Telmisartan (ARB) blocks angiotensin II receptors, reducing blood vessel constriction and protecting kidneys. Amlodipine (calcium channel blocker) relaxes and widens arterial walls. Together they lower blood pressure through two complementary mechanisms, providing greater reduction than either drug alone.

Indications

Hypertension requiring combination therapy, cardiovascular risk reduction, hypertension in diabetic patients (Telmisartan has renoprotective benefit), and hypertension with angina (Amlodipine relieves anginal symptoms).

Dosage & Administration

Take as prescribed by your doctor or healthcare professional. Do not self-medicate.

Why LEADTEL AM?

ARB + CCB is the most prescribed dual antihypertensive combination globally. The 150-tablet economy pack supports the chronic daily prescribing this indication requires.

Interested in franchising LEADTEL AM?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top